Show simple item record

dc.contributor.authorB Demiray, S
dc.contributor.authorAyla, Ş
dc.contributor.authorOltulu, F
dc.contributor.authorÇavuşoğlu, T
dc.contributor.authorAkarca, Ö
dc.contributor.authorY Dilsiz, Ö
dc.contributor.authorErgüven, M.
dc.contributor.authorÖktem, G
dc.date.accessioned2021-12-21T08:31:26Z
dc.date.available2021-12-21T08:31:26Z
dc.date.issued2011
dc.identifier.issn1016-9113
dc.identifier.issn2147-6500
dc.identifier.urihttps://app.trdizin.gov.tr/makale/TVRNME1EVTFOUT09/mdah-2774-over-kanser-kok-hucrelerinde-kemoterapi-sonrasi-apoptotik-etkilerin-incelenmesi
dc.identifier.urihttp://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/740
dc.description.abstractAmaç: Mortalitesi en yüksek jinekolojik kanser olan over kanserinin tedavisindeki asıl problem nüks ve kemoterapi direncidir. Kanser dokusunda, patogenezisden sorumlu tutulan, artmıs büyüme potansiyeline sahip, uzun ömürlü hücre popülasyonu kanser kök h
dc.description.abstractAim: A major problem in the treatment of ovarian cancer, which has the highest mortality rates among gyneacological malignancies, is recurrence and chemoresistance. In the cancer tissue, this population of long-lived cells with extraordinary expansion p
dc.language.isoTurkish
dc.titleMDAH- 2774 over kanser kök hücrelerinde kemoterapi sonrası apoptotik etkilerin incelenmesi
dc.title.alternativeApoptotic effects of chemotheraphy in the MDAH- 2774 ovarian cancer stem cell
dc.relation.journalEge Tıp Dergisi
dc.identifier.issue2
dc.identifier.startpage103
dc.identifier.endpage109
dc.identifier.volume50
dc.relation.issue2
dc.relation.volume50


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record